SWICH, Inc.
  • Sign In

  • My Account
  • Signed in as:

  • filler@godaddy.com


  • My Account
  • Sign out

  • Home
  • Research
  • Consulting
  • Contact
  • ARIP Portal
  • More
    • Home
    • Research
    • Consulting
    • Contact
    • ARIP Portal
SWICH, Inc.

Signed in as:

filler@godaddy.com

  • Home
  • Research
  • Consulting
  • Contact
  • ARIP Portal

Account


  • My Account
  • Sign out


  • Sign In
  • My Account

Strategic Research Services

Independent research and in-depth analytics, specializing in systems thinking, predictive modeling, logic, and data-driven investigation. We bridge intuition, insight, and dialectic reasoning with AI-augmented research methodologies to develop strategic output that delivers clarity, foresight, and measurable results.

AI-Augmented Research & Insight Platform (ARIP)

Download PDF

LATEST RESEARCH (ARIP-Generated)

ARTICLE 14 - CBL-iO3-TMDE (22-FEB-26)

Download PDF

CBL - iO3 Research Series (2025)

CBL-iO3 Research Series ARTICLE 1 (18-AUG-25) (pdf)

Download

CBL-iO3 Research Series ARTICLE 2 (revised 06-SEPT-25) (pdf)

Download

CBL-iO3 Research Series ARTICLE 3 (28-AUG-25) (pdf)

Download

CBL-iO3 Research Series ARTICLE 4 (11-SEPT-25) (pdf)

Download

CBL-iO3 Research Series ARTICLE 5 (11-SEPT-25) (pdf)

Download

CBL-IO3 Research Series ARTICLE 6 (22-SEPT-25) (pdf)

Download

CBL-iO3 Research Series ARTICLE 6a (24-SEPT-25) (pdf)

Download

CBL-iO3 Research Series ARTICLE 7 (28-SEPT-25) (pdf)

Download

CBL-iO3 Research Series ARTICLE 8 (18-OCT-25) (pdf)

Download

CBL-iO3 Research Series ARTICLE 9 (27-OCT-25) (pdf)

Download

CBL-iO3 Research Series ARTICLE 10 (2-NOV-25) (pdf)

Download

CBL-iO3 Article 11 FINAL (11-NOV-25) (pdf)

Download

ARTICLE 12 Supplemental Update (27-NOV-25) (pdf)

Download

Article 12 FINAL (26-NOV-25) (pdf)

Download

Article 13 - From Platform to White Knight v1. 7.42.40 AM (pdf)

Download

CONSCIOUSNESS SERIES - ARTICLE 11 (29-NOV-25)

Download PDF

CONSCIOUSNESS Series (2025)

ARTICLE 1 - Theory of Nothing v1.4 (9-NOV-25) (pdf)

Download

ARTICLE 2 - The Living Circuit v1.5 (15-NOV-25) (pdf)

Download

ARTICLE 3 - The Cosmic Trinity v1.6 (19-NOV-25) (pdf)

Download

ARTICLE 4 - The Universal Equilibriumv1.5 (19-NOV-25) (pdf)

Download

ARTICLE 5 - The Cosmological Information Model v1.2 (21-NOV-25) (pdf)

Download

ARTICLE 6 v1.1 (23-NOV-25) (pdf)

Download

ARTICLE 7 V1.0 (23-NOV-25) (pdf)

Download

ARTICLE 8 v1.1 (24-NOV-25) (pdf)

Download

ARTICLE 9 v1.0 (24-NOV-25) (pdf)

Download

ARTICLE 10 v1 (24-NOV-25) (pdf)

Download

Oragenics Research Series (2025)

Oragenics Research Series ARTICLE 1 (02-SEPT-25) (pdf)

Download

Oragenics Research Series ARTICLE 2 (22-SEPT-25) (pdf)

Download

ARCHIVED research Articles

Adcore_ A Treasure Hiding In Plain Sight (OTCMKTS_ADCOF) _ Seeking Alpha (pdf)Download
Aytu BioScience (AYTU)_ The Moonshot Continues To Orbit Awaiting The Next Giant Steps _ Seeking Alpha (pdf)Download
Pacific Green Technologies_ Evolving Into An Environmental Powerhouse (PGTK) _ Seeking Alpha (pdf)Download
Photon Control_ Best Supporting Actor In A New Economy Role (OTCMKTS_POCEF) _ Seeking Alpha (pdf)Download
Photon Control Stock_ A Virtuoso Performer In The Semiconductor Industry (OTCMKTS_POCEF) _ Seeking Alpha (pdf)Download
SONO-TEK_ A True American Success Story (OTCMKTS_SOTK) _ Seeking Alpha (pdf)Download

Emerging inventions (VLOG)

Mark Pimentel, MD, is the head of the Pimentel Laboratory and executive director of the Medically Associated Science and Technology (MAST) Program at Cedars-Sinai. This program focuses on the development of drugs, diagnostic tests, and devices related to conditions of the microbiome.  In this Q&A session, Dr. Pimentel discusses his path from growing up in Thunder Bay, Ontario, Canada to leading one of the world's most renowned medical research institutes. 

Strategic Analyses Disclaimer

These reports have been prepared for informational and educational purposes only. They represent independent research and speculative analysis by the author, based solely on publicly available sources such as SEC filings, financial statements, trading data, press releases, and industry research.

These reports:

  • Do not contain or rely on insider information.
  • Do not constitute investment, financial, legal, or professional advice.
  • Do not guarantee the occurrence of any event or transaction discussed.

All forward-looking statements, including references to potential mergers, acquisitions, valuations, or strategic outcomes, should be interpreted strictly as hypotheses — not predictions or commitments. Readers should conduct their own due diligence and consult qualified advisors before making investment or strategic decisions.


Copyright © 2026 SWICH, Inc. - All Rights Reserved.

Powered by

This website uses cookies.

We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.

Accept